Open in app

Sign In

Write

Sign In

Dan Sfera
Dan Sfera

959 Followers

Home

About

Sep 2, 2021

Analysts upgrade forecast for immunooncology company

Agenus on the Move Analysts have just delivered a major upgrade to the near-term forecasts for Lexington, Massachusetts-based Agenus, Inc., reported Simply Wall Street. Consensus numbers for revenue and earnings per share (EPS) increased, with the analysts’ views much more bullish on the company’s business prospects. …

Oncology

4 min read

Oncology

4 min read


Sep 2, 2021

Two top FDA vaccine regulators are leaving

Stepping Down Marion Gruber and Phil Krause, two of the Food and Drug Administration’s top vaccine reviewers, are leaving the agency just as a decision on COVID-19 boosters is imminent. Both intend to step down from the FDA within the next two months. Gruber, who has been with the FDA…

FDA

3 min read

FDA

3 min read


Sep 2, 2021

FDA finalizes intended use rule

Resolution to Confusion The US Food and Drug Administration (FDA) finally finalized a rule that clarifies its position on the types of evidence it will consider when determining the intended use of a medical product. …

Clinical Trials

3 min read

Clinical Trials

3 min read


Aug 29, 2021

Synthetic Biology Hype? Zymergen rallies after Cathie Wood recommendation

Roller Coaster Zymergen, which researches, develops and manufactures microbes for industrial application, develops molecules for biomedical coatings and adhesives that can be used as surgical glues inside the body or on the skin to close a wound or to protect against infection. …

Zymergen

2 min read

Zymergen

2 min read


Aug 29, 2021

Jazz Pharmaceuticals drug gets approval

Solving Sleep Disorders The US Food and Drug Administration (FDA) approved Dublin-based Jazz Pharmaceuticals’ Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of idiopathic hypersomnia in adults. Idiopathic hypersomnia is a debilitating neurological sleep disorder characterized by chronic excessive daytime sleepiness, explained Pharma Times. According to…

Jazz Pharmaceuticals

3 min read

Jazz Pharmaceuticals

3 min read


Aug 29, 2021

Lilly forms neuroscience unit

Shorter Path to Market Eli Lilly & Co. announced on August 17 that it will split its Lilly Bio-Medicines division into two business units: Lilly Neuroscience and Lilly Immunology, effective September 5, reported Tonya Garcia in MarketWatch. …

Eli Lilly

3 min read

Eli Lilly

3 min read


Aug 29, 2021

Personal genomics firm becomes holding company via merger

Is 23 and Me for You? 23andMe, Inc., a publicly held personal genomics and biotechnology company based in Sunnyvale, California, was founded by Linda Avey, Paul Cusenza and Anne Wojcicki in 2006 to provide genetic testing and interpretation to individual consumers. The company is best known for providing a direct-to-consumer…

23andme

3 min read

23andme

3 min read


Aug 25, 2021

Making Sense of Senseonics

Stock rises and falls as FDA approval is pending Senseonics of Germantown, Maryland, produces the Eversense CGM (continuous glucose monitoring) product that it claims is the first implantable device to monitor glucose levels. The market for diabetic care is growing fast. The disease is among the top 10 causes of…

Senseonics

5 min read

Senseonics

5 min read


Aug 17, 2021

Centessa merges 10 privately held biotechs under one umbrella

New Model Pharma In February Centessa Pharmaceuticals launched a new kind of pharmaceutical R&D model with $250 million Series A Financing. The company, which was founded by Medicxi, described itself as a merger of 10 privately-held biotech companies with highly validated programs. …

Biotechnology

5 min read

Biotechnology

5 min read


Aug 4, 2021

Salarius lead candidate is in nine U.S. trial sites

Answers for Cancer Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focusing on the development of drugs targeting rare, orphan cancers and cancers with a high unmet need, has added Fox Chase Cancer Center Center in Philadelphia to its ongoing trial of seclidemstat as a treatment for Ewing Sarcoma and…

Biotech Stock

4 min read

Biotech Stock

4 min read

Dan Sfera

Dan Sfera

959 Followers

Entrepreneur. Clinical Trials. 👋🏻. Arizona Wildcat for life. http://www.TheClinicalTrialsGuru.com

Following
  • Mitch Jackson

    Mitch Jackson

  • M.G. Siegler

    M.G. Siegler

  • David McNierney

    David McNierney

  • Ryan Holiday

    Ryan Holiday

  • Jared

    Jared

Help

Status

Writers

Blog

Careers

Privacy

Terms

About

Text to speech